Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mebeverine For Daytime And Nocturnal Incontinence and After Orthotopic W-Ileal Neobladders - Assessment Of Efficacy And Quality Of Life Effect Within 1 Year Post-Surgery: A Randomized Controlled Study

NCT03147599 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT03147599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03147599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mebeverine For Daytime And Nocturnal Incontinence and After Orthotopic W-Ileal Neobladders - Assessment Of Efficacy And Quality Of Life Effect Within 1 Year Post-Surgery: A Randomized Controlled Study
Lead sponsor
Mansoura University
Phase
Phase 4
Overall status
Completed
Start date
May 15, 2017
Completion date
May 1, 2019
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, incontinence, incontinence, daytime urinary, incontinence, nighttime urinary, oncology, orthotopic neobladder